PT799039E - Utilizacao de agentes anivirais de aminopurina para o tratamento e profilaxia de infeccoes latentes pelo virus do herpes - Google Patents

Utilizacao de agentes anivirais de aminopurina para o tratamento e profilaxia de infeccoes latentes pelo virus do herpes

Info

Publication number
PT799039E
PT799039E PT95941044T PT95941044T PT799039E PT 799039 E PT799039 E PT 799039E PT 95941044 T PT95941044 T PT 95941044T PT 95941044 T PT95941044 T PT 95941044T PT 799039 E PT799039 E PT 799039E
Authority
PT
Portugal
Prior art keywords
prophylaxia
aniviral
aminopurin
agents
treatment
Prior art date
Application number
PT95941044T
Other languages
English (en)
Inventor
Hugh John Field Centre Science
Alana Maureen Thack Veterinary
Teresa Helen Bacon Smi Beecham
David Sutton S Pharmaceuticals
Richard Anthony Vere H Beecham
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT799039(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425012.3A external-priority patent/GB9425012D0/en
Priority claimed from GBGB9506663.5A external-priority patent/GB9506663D0/en
Priority claimed from GBGB9517308.4A external-priority patent/GB9517308D0/en
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of PT799039E publication Critical patent/PT799039E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT95941044T 1994-12-12 1995-11-23 Utilizacao de agentes anivirais de aminopurina para o tratamento e profilaxia de infeccoes latentes pelo virus do herpes PT799039E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9425012.3A GB9425012D0 (en) 1994-12-12 1994-12-12 Pharmaceuticals
GBGB9506663.5A GB9506663D0 (en) 1995-03-31 1995-03-31 Pharmaceuticals
GBGB9517308.4A GB9517308D0 (en) 1995-08-24 1995-08-24 Pharmaceuticals
US08/522,790 US5840763A (en) 1994-12-12 1995-09-01 Treatment of a latent infection of herpes viruses

Publications (1)

Publication Number Publication Date
PT799039E true PT799039E (pt) 2002-04-29

Family

ID=27451235

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95941044T PT799039E (pt) 1994-12-12 1995-11-23 Utilizacao de agentes anivirais de aminopurina para o tratamento e profilaxia de infeccoes latentes pelo virus do herpes

Country Status (24)

Country Link
US (2) US5840763A (pt)
EP (1) EP0799039B1 (pt)
JP (1) JP2008088189A (pt)
CN (1) CN1098687C (pt)
AP (1) AP669A (pt)
AT (1) ATE208198T1 (pt)
AU (1) AU699627B2 (pt)
BG (1) BG63815B1 (pt)
BR (1) BR9509986A (pt)
CA (1) CA2207503C (pt)
CY (1) CY2339B1 (pt)
CZ (1) CZ291545B6 (pt)
DE (1) DE69523776T2 (pt)
DK (1) DK0799039T3 (pt)
ES (1) ES2166834T3 (pt)
HK (1) HK1003259A1 (pt)
HU (1) HU222835B1 (pt)
NO (1) NO313862B1 (pt)
NZ (1) NZ297424A (pt)
PT (1) PT799039E (pt)
RO (1) RO120042B1 (pt)
SI (1) SI0799039T1 (pt)
SK (1) SK282983B6 (pt)
WO (1) WO1996018396A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
US6047209A (en) * 1999-04-02 2000-04-04 Denny; Jeffrey Paul Method and apparatus for maintenance of pierced orifices
CL2006000697A1 (es) * 2005-03-30 2008-05-09 Novartis Ag Uso de famciclovir para el tratamiento del herpes labial recurrente.
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
EP3753563A1 (en) * 2019-06-20 2020-12-23 Helmholtz-Zentrum für Infektionsforschung GmbH Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses

Also Published As

Publication number Publication date
AP9701001A0 (en) 1997-07-31
ATE208198T1 (de) 2001-11-15
HU222835B1 (hu) 2003-11-28
CN1175212A (zh) 1998-03-04
AU4257896A (en) 1996-07-03
BG101608A (en) 1998-02-27
SK282983B6 (sk) 2003-01-09
CZ291545B6 (cs) 2003-04-16
US5916893A (en) 1999-06-29
CA2207503A1 (en) 1996-06-20
NO972688D0 (no) 1997-06-11
NO972688L (no) 1997-08-07
CZ179997A3 (en) 1997-09-17
WO1996018396A1 (en) 1996-06-20
CY2339B1 (en) 2004-02-06
US5840763A (en) 1998-11-24
NO313862B1 (no) 2002-12-16
AU699627B2 (en) 1998-12-10
DE69523776T2 (de) 2002-08-01
BR9509986A (pt) 1997-11-25
CN1098687C (zh) 2003-01-15
ES2166834T3 (es) 2002-05-01
SK75197A3 (en) 1997-11-05
EP0799039B1 (en) 2001-11-07
HUT77437A (hu) 1998-04-28
EP0799039A1 (en) 1997-10-08
JP2008088189A (ja) 2008-04-17
DE69523776D1 (de) 2001-12-13
DK0799039T3 (da) 2002-01-28
BG63815B1 (bg) 2003-02-28
NZ297424A (en) 2000-07-28
MX9704336A (es) 1997-09-30
SI0799039T1 (en) 2002-06-30
AP669A (en) 1998-09-04
HK1003259A1 (en) 1998-10-23
CA2207503C (en) 2006-07-18
RO120042B1 (ro) 2005-08-30

Similar Documents

Publication Publication Date Title
BR9508886A (pt) Compostos e métodos para o tratamento de câncer
PT98944A (pt) Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
KR950700732A (ko) 알러지성 및 염증성 질환의 치료에 유용한 화합물(Compounds useful for treating allergic and inflammatory diseases)
PT8866U (pt) Entressola aperfeicoada para calcado
GB9709360D0 (en) Methods for the treatment of herpes virus infections
BR9609695A (pt) Composição herbicida sinérgica e processo para seu uso
BR9302433A (pt) Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmas
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
PT799039E (pt) Utilizacao de agentes anivirais de aminopurina para o tratamento e profilaxia de infeccoes latentes pelo virus do herpes
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
BR9301567A (pt) Aparelho para o tratamento magnético de combustível
ZA926963B (en) Method of treating latent herpes viral infections.
PT8969T (pt) Dispositivo aperfeicoado, para abertura de fechaduras
BR9305707A (pt) Processo para preparaçao de 3-acilestratrienos e acilbenzenos
PT804199E (pt) Uso de penciclovir para o tratamento de nevralgias pos-herpeticas
BR9804794A (pt) Processo para prepara-Æo de 1-alquil-4-(2-cloro-3-alcÄxi-4-alquil-sulfonil-benzoil) -5-hidrÄxi-pirazol e compostos relacioonados
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
NO954390D0 (no) Fremgangsmåte for bekjempelse av acyklovir-resistente Herpes simplex virus-infeksjoner
BR9104420A (pt) Processo para fabricacao de 2-aminoditiotiazois e de 2-aminotritiotiazois
BR9507375A (pt) Tratamento de superficies particuladas
BR9300468A (pt) Processo para preparacao de 2-hidroxi-4,6-diaril-1,3,5-triazinas e utilizacao
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
MX9100857A (es) Procedimiento para la purificacion de 4-acetoxiestireno